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The emergence and dissemination of bacterial antimicrobial resistance has become a 
major public health concern. A total of 444 manure composite samples were collected 
from 80 dairy farms in Pennsylvania, representing pre-weaned calves, post-weaned 
calves, dry cows, and lactating cows. E. coli and Salmonella were isolated, and tested 
for antimicrobial susceptibility. Salmonella was isolated from at least one sample 
from 51 (64%) farms and was more prevalent in adult animals than young animals. 
The predominant serotypes were Cerro, Montevideo and Kentucky. Salmonella 
isolates were mostly susceptible to all antimicrobials. E. coli were commonly 
resistant to tetracycline, streptomycin, sulfisoxazole and ampicillin. Resistance of up 
to 8 classes of antibiotics was observed in E. coli isolated from young animals. The 
blaCMY- and blaCTX-M-carrying E. coli were detected in 35% and 5% of the farms, 
respectively. The presence of multi-drug resistant E. coli suggested potential risks to 
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Chapter 1: Introduction 
The emergence and dissemination of antimicrobial resistance in bacteria has 
become a major public health concern (WHO, 2014). In clinical settings, pathogens 
resistant to multiple classes of important antibiotics could complicate the treatment by 
significantly limiting therapeutic options. Infections caused by drug resistant bacteria 
can lead to failure of treatment, prolonged hospital stays, higher health care 
expenditures, and increased morbidity and mortality (ECDC, 2013). β-lactams, 
including cephalosporins, are a class of antibiotics of critical importance in human 
medicine (WHO, 2014). Ceftriaxone, one of the third-generation cephalosporins, is 
used for treatment of severe salmonellosis in children (Rabsch et al., 2001). The 
increasing prevalence of resistance to first-, second-, and third-generation 
cephalosporins has been reported worldwide in isolates from food-producing animals. 
Resistance to cephalosporins in Enterobacteriaceae, including E. coli and Salmonella, 
is mainly caused by production of AmpC-type β-lactamases and Extended spectrum 
β-lactamases (ESBLs) (Bonnet, 2004; Zhao and Hu, 2012). The ESBL/AmpC genes 
are often located on plasmids of Enterobacteriaceae that able to transfer intra-species 
and inter-species.  
The objective of this study was to conduct a cross–sectional survey of dairy 
farms in Pennsylvania to investigate the scope of resistance problem. Rather than 
focusing on either lactating cows or pre-weaned calves exclusively, four different 
animal groups were examined on each farm, including pre-weaned calves, post-




Chapter 2: Literature Review 
2.1 Burden of antimicrobial resistance 
The emergence and dissemination of antibiotic resistance (AR), including 
multidrug resistance (MDR), is an increasing problem around the world. 
Antimicrobial resistance is the phenomenon when a microorganism survives 
exposure to an antimicrobial agent at a concentration to which wild-type forms are 
normally susceptible. MDR is commonly defined as resistance to three or more 
classes of antibiotics. When infection occurs in community, MDR human 
pathogens are able to withstand attack by several classes of antibiotics. MDR can 
then greatly limit the choices of antibiotic therapy, resulting in substantial 
economic burden to the society. Infections associated with AR cost an estimated 
$20 billion in excess health care expenses and $35 billion in other societal costs 
annually in the U.S. (CDC), 2013) and cost €1.5 billion annually the European 
Union (EPHA, 2012).  
In clinical settings, antibiotic resistance is also implicated in failure to 
respond to the standard treatment, prolonged illness, and a greater risk of death, in 
addition to the increased treatment costs (WHO, 2014). It is estimated that in the 
U.S. more than 2 million people are infected with AR bacteria annually, with 
23,000 deaths as a direct result (CDC, 2013). In Europe 25,000 people die each 
year as a result of MDR bacterial infection (European Commssion, 2011).  
When infections persist due to the ineffectiveness of antibiotics, the chance 
of spread of the resistant bacteria would increase. The global emergence and 




common infectious diseases. It has become very difficult to stay ahead of the rapid 
acquisition of AR by some important pathogens (Doyle, 2015). For example, 
resistance to one of the most widely used antibacterial drugs for the oral treatment 
of urinary tract infections, fluoroquinolones, caused by E. coli is very widespread. 
Moreover, resistance to the treatment of last resort for life-threatening infections, 
carbapenem antibiotics, caused by gastrointestinal pathogens has spread to all 
regions of the world: key tools to tackle the resistance problem are tracking and 
monitoring resistance to reveal information gaps (WHO, 2014). 
 
2.2 Acquired resistance mechanisms to major antibiotic classes 
Although much attention has been focused on AR in pathogens, the 
development of resistance to antibiotics is a natural ecological phenomenon and 
genes for resistance to antibiotics, like the antibiotics themselves, are ancient 
(D’Costa et al., 2011). Ancient resistance genes in a microorganism could be a 
product of a series of spontaneous or induced genetic mutations. Exposure to an 
antibiotic naturally selects the strain carrying the corresponding resistance gene. 
The reservoir of resistance genes can be mobilized and can transfer into human 
pathogens (Blair et al., 2011). For example, many antibiotic resistance genes 
reside on transmissible genetic elements, such as plasmids and transposons, 
facilitating them to transfer inter-species. Horizontal transfer of resistance genes 
could also occur through transduction or transformation. It has been observed that 
plasmids and transposons sometimes contain genes conferring resistance to several 




Researchers have been trying to understand the mechanisms by which bacteria 
successfully defend themselves against actions of antibiotics (Lin et al., 2015). 
Acquired resistance mechanisms play critical roles in the emergence and 
dissemination of resistance in the “post-antibiotic” era. Acquired resistance 
mechanisms can be categorized into three groups: elimination of the intracellular 
concentrations of the antibiotic, modification of the antibiotic target, and inactivation 
of the antibiotic. A good example of the first mechanism is efflux pump. The 
multidrug efflux systems contribute significantly to the increased resistance to 
multiple antibiotics in bacteria (Lin, 2015).  
Mutation of the target site is another important mechanism, and usually 
results in a functional target with reduced affinity for the antibiotic, which does 
not bind efficiently and therefore has a reduced effect (Blair, 2015). A good 
example is mutations in topoisomerase genes in many species that confer 
fluoroquinolone resistance. Fluoroquinolones are regarded as critically important 
antimicrobial agents for human medicine according to WHO criteria, and cross-
resistance to fluoroquinolones such as ciprofloxacin (a metabolite of enrofloxacin 
which is approved for treatment of food-producing animals) poses a formidable 
threat to public health (Collignon et al., 2009). In gram-negative bacteria, such as 
E. coli, high levels of quinolone resistance are mainly due to mutation of the genes 
encoding for the gyrase subunits gyrA. 
In addition, bacteria can destroy or modify antibiotics, thus resisting their 
action in the form of hydrolyzing the antibiotic or addition of a chemical group 




modify antibiotics of different classes, including β-lactams, aminoglycosides, 
phenicols and macrolides. β-lactam antibiotics are the most widely available 
antibiotics used to treat a number of bacterial infections and the subclasses include 
cephalosporins, penicillins, carbapenems, monobactams and clavams. Members of 
β-lactam antibiotics contain a β-lactam ring and take effect by inhibiting proper 
cross-linking of bacterial cell walls (Lin, 2015). Resistance to β-lactam antibiotics 
is mainly due to production of β-lactamase, an enzyme that inactivates the drug.  
The early β-lactamases, such as TEM-1 and SHV-1 β-lactamases, which 
were active against first-generation β- lactamases were followed by extended-
spectrum β-lactamases (ESBLs) which become active against third-generation 
cephalosporins. ESBLs have emerged in parallel and disseminated through enteric 
bacteria of both humans and animals. In most cases, ESBLs are not capable of 
hydrolyzing cephamycins e.g., cefoxitin, and are readily inhibited by clavulanic 
acid e.g., Augmentin (amoxicillin/clavulanic acid) (Bell and Fisher, 2009). ESBLs 
are found in many members of Enterobacteriaceae and one type of ESBL that is 
increasingly detected is the CTX-M family, which is plasmid mediated and 
notable for greater activity against cefotaxime. The original source of the gene 
encoding the CTX-M ESBLs is the chromosome of the enteric bacterium, 
Kluyvera ascorbate, that was originally isolated from humans (Humeniuk et al., 
2002). K. ascorbata is a commensal bacterium of both humans and animals, and 
selective pressure led to the mobilization of its beta-lactamase onto a plasmid, 
which was then shared among commensal bacteria such as E. coli (Humeniuk et 




centers reported E. coli or Klebsiella pneumonia infections with strain carrying 
associated blaCTX-M genes (Castanheira et al., 2008).  
Another type of plasmid-mediated cephalosporinase has arisen through 
transferring of genes coding for the chromosomal AmpC β-lactamases, which 
contribute greatly to cephalosporin resistance in E. coli, K. pneumonia and 
Salmonella species (Bell and Fisher, 2009). This type of β-lactamases cannot be 
inhibited by clavulanic acid. Other newly emerged type of β-lactamases are 
carbapenemases, including the IMP (imipenemase), VIM (Verona integrin 
encoded metallo β-lactamase), KPC (K. pneumonia carbapenemase), and OXA 
(oxacillinase). They have serious implications in hospital settings, but have rarely 
been detected in isolates from food-producing animals.  
Aminoglycosides are another class of clinically important antibiotics for 
treating various bacterial pathogens. Examples of aminoglycosides are gentamicin, 
tobramycin, streptomycin and kanamycin. The increasing resistance of clinical 
isolates against aminoglycosides, however, has compromised the effectiveness of 
this class of antibiotics. Aminoglycosides act by binding to the 30S subunit of the 
prokaryotic ribosome and interrupting the translation process. Aminoglycoside 
antibiotics are particularly susceptible to modification as they tend to be large 
molecules with many exposed hydroxyl and amide groups. Production of 
aminoglycoside-modifying enzymes was considered as the major mechanisms for 




2.3 Impact of antibiotic use in food-producing animals 
Antibiotics are used in food-producing animals for treatment of disease and 
are critical for animal welfare and food safety. Regardless of the benefits of using 
antimicrobial agents in food-producing animals, concerns from public health, food 
safety, and regulatory perspectives arise from the potential for development of 
antimicrobial resistance (Oliver et al., 2011). Research has been conducted to 
understand the role of agricultural antibiotic usage in the global AR emergence 
and dissemination problem. Recent analyses of metagenomics sequences from 
beef cattle feces, chicken ceca, and swine feces all reveal an abundance of 
resistance genes regardless of antibiotic treatment. In a study of conventionally 
raised beef cattle with no exposure to therapeutic antibiotics, sequence-based 
metagenomics predicted that 3.7% of the sequences encoded resistance to 
antibiotic and toxic compounds; around 50% of genes harbor multi-drug resistance 
efflux pumps (Durso et al., 2011).  
Evidence supports agricultural usage of antibiotics was linked to the 
increasing prevalence of resistance. Among seven European countries for whom 
antibiotic use and antibiotic resistance data were available, a clear correlation was 
seen between antibiotic use and resistance gene prevalence in food animals 
(Chantziaras et al., 2014). However, knowledge gap exists in data supporting the 
direct link of antibiotic use and emergence of resistance. Little is known about the 
distribution of the resistance bacteria in different reservoirs on farm and how the 
reservoirs assist its persistence. Another knowledge gap lies in data on the 




human pathogens (Oliver et al., 2011). Understanding the dynamics is important 
because increased antibiotic resistance in human pathogens can seriously threaten 
public health. Humans may potentially be exposed to antimicrobial resistant 
pathogens through a variety of routes, including foods from livestock carrying 
resistant bacteria, direct contact with farm animals, farm environments, fresh 
produce fertilized by contaminated manure, and irrigation water carrying resistant 
pathogens. Li et al. (2014) have shown that groundwater can be potentially 
contaminated by antibiotic resistant bacteria originated from dairy farm. Survival 
of drug-resistant bacteria in manure and waste lagoons was observed in two dairy 
farms in California resulting spread from these sources to ground water (Li et al., 
2014). River water downstream from concentrated animal feeding operations in 
the U.S. contained much higher levels of MDR bacteria than the reference sites 
(West et al., 2011). 
 
2.4 Monitoring resistance in livestock and food  
In the U.S., the National Antimicrobial Resistance Monitoring System 
(NARMS), a collaborative effort among the U.S. Food and Drug Administration 
(FDA), Centers for Disease Control and Prevention (CDC) and U.S. Department 
of Agriculture (USDA), tracks changes in the susceptibility of bacteria to 
antimicrobial agents of importance. Bacteria monitored in NARMS are not only 
clinical human isolates, but also isolates from retail meats and food-producing 
animals. According to NARMS 2011 Retail Meat Report, MDR Salmonella and 




Salmonella and E. coli isolated from the ground beef samples (NARMS, 2013). 
Moreover, MDR Salmonella was recovered from 28.7% of cattle carcass swabs 
obtained at federally inspected slaughter and processing plants. Prevalence of 
MDR E. coli was 38.3% in chicken carcass, and 37.5% in retail chicken; 
prevalence of MDR Salmonella was 27.9% in swine, and 28.6% in pork chop 
(NARMS, 2013).  
European Food Safety Authority (EFSA) and European Centre for Disease 
Prevention and Control (ECDC) also publish a yearly report on antimicrobial 
resistance in bacterial isolates from humans, livestock and food. The MDR 
Salmonella spp., in cattle was reported to be 34.2% in 2012, which was lower than 
Salmonella prevalence in poultry and swine, respectively. MDR Salmonella 
isolates from retail chicken (64.2%) and pork (50.9%). In livestock, MDR 
Salmonella were isolated from 46.4% of the poultry isolates and 73.5% of the 
swine isolates. MDR E. coli was 1.1% in broilers and 30.9% in pigs, and data are 
not available for E. coli in retail meat (EFSA, 2014).  
 
2.4.1 Salmonella serotype and resistance in retail meat 
The latest NARMS 2013 Retail Meat Interim Data revealed the top 
serotypes among Salmonella isolates from retail ground beef samples collected in 
2013. Fifteen Salmonella isolates from 1663 ground beef samples belong to 
serotype Dublin (26.7% 4 isolates), Montevideo (26.7% 4 isolates), Infantis 
(13.3% 2 isolates), Kentucky (6.7% 1 isolates), and others. Among the 15 isolates, 




quinolones or macrolides (azithromycin) (FDA, 2015). However when compared 
with retail chicken (19.7%), ground turkey (9.4%) and pork chop (0%),  
prevalence of ceftriaxone resistant Salmonella (26.7%) among Salmonella isolates 
from ground beef was higher. Multidrug resistant Salmonella (5) was detected 
among 33.3% of isolates, which was comparable to pork chop prevalence, but 
higher than retail chicken prevalence (26%), and lower than ground turkey 
prevalence (39.6%). The 2012 Retail Meat Report showed the top serotypes 
among Salmonella isolates from retail ground beef (n=13 N=1300 1.0%) were 
Dublin (30.8 % 4 isolates), Cerro (15.4%, 2 isolates), Newport (7.7%, 1 isolate), 
Kentucky (7.7%, 1 isolate), Typhimurium (7.7%, 1 isolate), Montevideo (7.7%, 1 
isolate), Anatum (7.7%, 1 isolate) and Agona (7.7%, 1 isolate). Among these 
isolates, all of the Cerro, Montevideo, Newport and Kentucky were pan-
susceptible, and 3 of the 4 S. Dublin were multidrug resistant (FDA, 2013). In 
comparison, Salmonella Kentucky isolated from retail chicken were mostly 
(88.7%) resistant to at least one antibiotic, with 22.6% of them being multidrug 
resistant and 21.0% exhibiting resistance to ceftriaxone.  
 
2.5 Emergence of multi-drug resistant Salmonella 
In the mid-1990s, widespread reports of Salmonella Typhimurium DT104 
in meats and livestock were the first indication of the emerging problem of 
resistance (Doyle, 2015). DT104 is resistant to amplicillin, chloramphenicol, 
streptomycin, sulfonamides, and tetracycline, a resistance pattern designated as 




including Salmonella Newport and Salmonella Heidelberg. The ACSSuT pattern 
has been found among different serotypes in human isolates and was identified in 
17% of Salmonella Typhimurium, 4% of Salmonella Newport, and 88% of 
Salmonella Dublin isolates according to NARMS 2012 report (CDC, 2014). 
Resistance to ceftriaxone and ciprofloxacin also increased during this time (EPHA, 
2012; WHO, 2014).  
MDR Salmonella Kentucky is another common serotype that may pose a 
threat to food safety. Highly drug-resistant Salmonella Kentucky ST198-X1 strain 
was recently detected in poultry flocks and turkey meat in Europe and Canada (Le 
Hello et al., 2013; Mulvey et al., 2013). In France during 2000-2008, about 40% of 
Salmonella Kentucky isolates were resistant to ciprofloxacin; in 2009-2011, the 
percentage increased to 83%. Some Salmonella strains were also observed to be 
resistant to carbapenems, fluoroquinolones, trimethoprim-sulfamethoxazole, and 
azithromycin (Le Hello et al., 2013). Based on the 2012 CDC NARMS Human 
Isolates Report, Enteriditis was the most common serotype among nalidixic acid-
resistant non-typhoidal Salmonella isolates, and the most common serotypes 
among ceftriaxone-resistant isolates were Newport (7%), Typhimurium (5%), 
Heidelberg (22%), and Dublin (75%). CDC (2014) reported that the resistance (to 
one or more Clinical and Laboratory Standards Institute antibiotic classes) among 
non-typhoidal Salmonella human isolates has decreased from 20% in 2003-2007 
to 15% in 2012; multidrug resistance (to three or more classes) decreased from 
12% to 9% in the same time period, but this was likely due to a reduction in 




2.6 Antibiotic use on dairy farm and development of resistance 
Antimicrobial agents that are currently licensed for use in dairy cattle in 
the U.S. include enrofloxacin, florfenicol, and various penicillins, cephalosporins, 
macrolides, sulfonamides, and tetracyclines; extralabel use of some additional 
drugs is also permitted under certain circumstances (APHIS, 2008). National data 
shows that the degree of prophylactic and therapeutic antimicrobial use on dairy 
operations across the U.S. remained essentially unchanged between the 2002 and 
2007 NAHMS Dairy studies (APHIS, 2008). Common uses for  antimicrobial 
agents on dairy farms include feeding of medicated milk replacer to pre-weaned 
calves, treatment of respiratory and gastrointestinal disease in pre-weaned calves, 
treatment of respiratory disease in weaned calves, prevention and treatment of 
mastitis in cows, and treatment of respiratory disease, reproductive disorders, and 
lameness in cows (APHIS, 2008).  
The most common disease in calves that results in the use of antimicrobial 
drugs is diarrhea, followed by pneumonia (APHIS, 2008). According to the last 
published NAHMS data in 2007, the most common drugs used to treat diarrhea 
belonged to the tetracycline (16%) and β-lactam (9%) classes (APHIS, 2008). In 
the same report, the 2 antimicrobial drugs most commonly used for treatment of 
respiratory disease were florfenicol (18%) and drugs belonging to the macrolide 
class (15%). Clinical laboratories routinely culture bovine fecal and 
gastrointestinal tract samples for E. coli only when whose samples have been 
obtained from calves, because E. coli enteritis and septicemia are important 




U.S. study, >81% of E. coli isolated from calves with diarrhea were MDR, 
whereas in Australia, 72.4% of Salmonella isolates associated with diarrhea in 
calves were susceptible to all drugs tested (Doyle, 2015). 
In addition to these drugs, two fluoroquinolone drugs (danofloxacin and 
enrofloxacin) are approved to use for food producing animals in the U.S., 
including cattle and swine. Enrofloxacin is approved to treat dairy cattle less than 
20 months of age for respiratory disease and control. Extra-label use of 
fluoroquinolones is strictly prohibited. Study has shown that intramuscular 
enrofloxacin administered to cattle and swine is partly metabolized to 
ciprofloxacin, and results in measurable concentrations of ciprofloxacin and 
enrofloxacin in intestinal contents (Wiuff et al., 2002). The presence of quinolones 
in the feces could pose selective pressure on intestinal bacteria. Because all 
quinolones have common mechanisms of resistance, resistance to one quinolone 
will usually result in resistance to all other quinolones and selection pressure from 
enrofloxacin treatment could result in the selection of resistance to cirprofoxacin 
(Hopkins et al., 2005). Even though the concentration might be nonlethal, the 
exposure to antimicrobial drugs can enrich pre-existing resistant mutants with very 
small fitness costs (Hughes and Andersson, 2012). Other studies showed increased 
resistance to quinolones in dairy cattle E. coli isolates in northeastern region 
(Cummings, 2014). These observations suggest a review of continuous judicious 
use of quinolones in veterinary medicine. 
In the U.S. an increasing trend of aminoglycoside resistance has been 




exposed to neomycin. Cross-resistance between gentamycin and other 
aminoglycosides such as neomycin could be an explanation. According to the 
2007 NAHMS Dairy study, 50% of U.S. dairy operations used neomycin and 
oxytetrcycline in medicated milk replacer for claves (APHIS, 2008). Alternatively, 
co-selection caused by gene linkage could cause resistance in the absence of 
selection pressure from a specific drug. 
Resistance of E. coli from calves in other countries has also been 
monitored. E. coli isolated from calves younger than one year of age in Austria, 
Germany and the Netherlands showed moderate to high resistance to ampicillin, 
streptomycin, sulfonamides and tetracyclines (EFSA, 2014). Resistance to 
chloramphenicol and gentamicin was reported remaining at relatively low levels. 
The occurrence of resistance to fluoroquinolones and third-generation 
cephalosporins was less common and resistance to cefotaxime was also very low. 
The reported resistance in E. coli isolates from calves of less than one year was 
higher than young cattle and adult cattle in Austria. 
 
2.7 Salmonella and resistance on dairy farms 
Dairy cattle are known reservoirs of Salmonella spp. and asymptomatic 
shedders pose substantial risk to food safety. The virulence and antimicrobial 
resistance of Salmonella spp. can vary greatly among serotypes. Salmonella 
Dublin, Newport, Typhimurium, etc., can cause clinical salmonellosis in both 
humans and cattle, and were frequently reported to carry multi-resistance genes. 




on farms without showing clinical symptoms in the animals. However, all 
Salmonella serotypes are considered human pathogens, and monitoring prevalence 
and antimicrobial resistance in Salmonella is significant for food safety. Dairy 
cattle can serve as a source of Salmonella transmission to people through 
contaminated ground beef, dairy products, produce, and water, as well as through 
direct contact. In the U.S., dairy cattle are an important source of lean or extra-lean 
ground beef and therefore dairy cattle might be a source of Salmonella infections 
in humans, because both whole cuts and ground beef derived from market dairy 
cows are at risk for contamination with Salmonella. Milk and dairy products are at 
risk of contamination prior to leaving the farm, usually as a result of inadvertent 
fecal contamination during the milking process (Van Kessel et al., 2013). 
Outbreaks of MDR serotype Newport and Typhimurium strains have been 
frequently associated with consumption of unpasteurized cheeses and undercooked 
retail meats. 
Antimicrobial susceptibility of bacteria isolates from dairy farm is also 
monitored by NAHMS Dairy studies that have been conducted by the U.S. 
Department of Agriculture every 5 to 6 years since 1996 (APHIS, 2009). In 
NAHMS Dairy 2002-2007 Survey, 176 Salmonella isolates representing 26 
serotypes were recovered from bulk tank milk and milk filters. MDR-AmpC type 
resistance was observed in all 14 Salmonella Newport exhibited, as well as Dublin 
(3 of 7), Typhimurium (2 of 5) and Infantis (1 of 2), Kentucky (4 of 22) and 
Anatum (1 of 13) (Van Kessel et al. 2013). A longitudinal study of the acquisition 




fairly common event. On-farm practices such as herd size and off-farm heifer 
raising were found significantly correlated with the introduction of new MDR 
salmonellae (Doyle, 2015).  
 
2.8 Judicious use of antibiotic on dairy farm and alternative approach 
A new proposed rule, Veterinary Feed Directive, encourages judicious use 
of antibiotics in animal agriculture, particularly for drugs that are important in 
human medicine. FDA (2013) published Guidance for Industry #213 in December 
2013, which announced a specific strategy for animal drug companies to 
voluntarily revise the labeling of their medically important antimicrobials used in 
the feed and water of food-producing animals to withdraw approved production 
uses and place the remaining therapeutic uses of these products under veterinary 
oversight by December 2016.  
Several approaches may be utilized for reducing antibiotic usage in 
livestock. These include use of immunomodulators that increase immune function 
and disease resistance of animals; timely inspections to identify and treat sick 
animals before disease spreads; maintenance of a hygienic and healthy living 
environment; and use of laboratory tests to detect animals at risk of developing 
disease (USDA, 2014). Farm practice approaches were shown to be affective to 
limit food animal morbidity and mortality while reducing the use of antimicrobial 
drugs (Pereira et al., 2014). A study by Berge et al. (2009) observed that calves in 
a conventional therapy had 70% more days with diarrhea than calves in the 









Chapter 3: Antimicrobial Resistance of Salmonella and E. coli 
from Pennsylvania Dairy Herds 
3.1 Introduction 
Antibiotics are used in food-producing animals in many countries for 
treatment of diseases, but sometimes also for growth promotion and prevention of 
infections. In the U.S., antibiotic use in dairy operations is highly regulated. 
According to 2007 National Animal Health Monitoring System (NAHMS) Dairy 
Survey conducted by the U.S. Department of Agriculture, antibiotics are commonly 
used to treat respiratory disorders and diarrhea in pre-weaned calves, respiratory 
disease in weaned calves, and mastitis in cows. Other antibiotic exposures include 
medicated milk replacer used by more than half of the U.S. dairy operations in pre-
weaned calves. In addition on 90 % of dairy operations, intramammary antibiotics are 
used in dry cows to prevent mastitis (APHIS, 2008). It has been suggested that the 
agricultural use and misuse of antibiotics in food-producing animals has provided 
selective pressure in the farm environment resulting in increased prevalence of 
antibiotic resistance (Economou and Gousia, 2015). Fecal carriage of resistant 
bacteria in food producing animals, including dairy cattle, has been reported. Even 
though resistance genes are sometimes present in the absence of anthropogenic 
selective pressure, antibiotic use in farm animals may aggravate the resistance 
problem by accelerating the transfer of resistance genes among bacterial species 
(including human pathogens), or assisting the clonal spread of resistant strains (Allen, 




Salmonella is a leading foodborne pathogen in the U.S. (Varma et al., 2005) 
and can be transferred to humans through contaminated food, water, or direct contact 
with infected animals. Human salmonellosis usually results in self-limiting diarrhea 
and does not require antibiotic treatment. However, in severe cases of invasive 
infections, antimicrobial therapy is required and thus, the spread of resistant 
Salmonella is a concern. Drug resistant non-typhoidal Salmonella is listed as a 
“serious” pathogen to combat in Antibiotic Resistance Threats in the U.S. reported by 
the CDC (2013). Dairy cattle are a well-documented reservoir for Salmonella. 
Salmonella can also cause disease in cattle, and sometimes even death. Clinical 
symptoms of salmonellosis in cattle include fever, diarrhea, anorexia, abortion, and 
decreased milk production. Cattle can also asymptomatically shed Salmonella in their 
feces for extended period of time without any apparent impact on health or 
production (Van Kessel et al., 2012).  
USDA Animal and Plant Health Inspection Service (APHIS) have been 
examining Salmonella occurrence and antibiotic resistance in the U.S. dairy 
operations via the NAHMS program. An increasing trend of Salmonella prevalence 
was observed in fecal samples of healthy cows based on results of NAHMS Dairy 
Studies. Salmonella prevalence increased from 21% in 1996 to 40% in 2007 on U.S. 
dairy operations (APHIS, 2009). The common Salmonella serotypes were Cerro, 
Kentucky, Montevideo, Muenster, Meleagridis, Mbandaka, and Newport. When 
tested for antimicrobial susceptibility, Salmonella isolates from the three NAHMS 
Dairy Studies showed relatively little resistance, with 89%, 83%, and 93% of all the 




In 2007, resistance to ceftriaxone in a single Salmonella isolate and multidrug-
resistance in S. Montevideo were observed for the first time in the NAHMS Dairy 
Study. Milk is inevitably contaminated by feces during the milking process, and thus 
serves as a good indicator for bacteria shedding by the lactating cows, including 
Salmonella. Van Kessel et. al. (2013) detected AmpC-type Salmonella from bulk tank 
milk and milk filters samples in NAHMS milk study. Cephalosporin resistant 
Salmonella was also isolated from beef cattle, dairy cattle, and milk samples. The 
National Antimicrobial Resistance Monitoring System (NARMS) in the U.S. have 
identified ceftiofur resistant Salmonella in beef cattle (Zhao, 2003).  
Generic E. coli are ubiquitous in the environment and play a dynamic role in 
the ecology of intestinal microflora. Most E. coli are nonpathogenic, however, their 
genome exhibits a high degree of heterogeneity and readily acquires genetic elements. 
Resistant E. coli have been commonly found in food-producing animals and could be 
a useful indicator organism to evaluate the presence of antimicrobial resistance in the 
general bacterial population. E. coli from dairy cattle may serve as a reservoir of 
resistance genes. The mobile genetic elements in dairy commensal E. coli could 
potentially transfer to human pathogens, such as Salmonella and Klebsiella. 
Enterobacteriaceae-associated blaCTX-M genes have become globally 
widespread within the past 30 years. In 2007, 48% of extended-spectrum 
cephalosporin-resistant E. coli from a clinical laboratory in Philadelphia, 
Pennsylvania were CTX-M type (McGettigan et al. 2009). CTX-M-type E. coli has 




first isolation in the U.S. was by Wittum et al. (2010) from sick and healthy dairy 
cattle samples collected in 2009 in Ohio. More recently, researchers from Washington 
State University detected the emergence of blaCTX-M E. coli in dairy cattle when 
testing fecal samples collected in 2011(Davis et al., 2015).  
Many research have shown the presence of resistant bacteria in dairy cattle. 
However, an in-depth characterization of bacterial resistance is needed to further 
understand the dynamics of antibiotic resistance on dairy farms. The objective was to 
determine the prevalence of antimicrobial resistance among Salmonella enterica and 
commensal Escherichia coli isolates from different animal groups on dairy farms in 
Pennsylvania. 
 
3.2 Materials and methods 
3.2.1 Sample collection 
Manure composite samples were collected from 80 dairy farms in 
Pennsylvania from November, 2013 to February, 2015. Up to 6 samples representing 
4 different age groups were obtained from each farm. One sample was collected from 
pre-weaned calves, one from post-weaned calves, one from dry cows, and up to three 
from lactating cows. The samples were placed into sterile vials, packed on ice, and 
shipped overnight to the USDA-ARS Environmental Microbial and Food Safety 




3.2.2 Bacterial isolation 
To isolate Escherichia coli, 45 ml of buffered peptone water was added to 5 
grams of sample and vortexed until well mixed. Approximately 30-40 μl was streaked 
onto CHROMagar EC plates (Hardy Diagnostics, Santa Maria, CA). Plates were 
incubated at 37°C for 18 to 24 hours and 5 presumptive E. coli isolates (blue 
colonies) from each sample were selected for further confirmation. When multiple 
phenotypes were present, at least one colony of each phenotype was selected. The 
presumptive E. coli colonies were transferred from Chromogenic EC plates onto 
Simmons Citrate Agar, MacConkey Agar, Sorbitol-MacConkey Agar and L-Agar 
plates (Lennox Broth base with 1.5% agar; Gibco Laboratories , Long Island, NY), 
and incubated at 37°C for 18-24h. Colonies that exhibited the E. coli phenotype 
(negative on Citrate agar, positive on MacConkey, positive or negative on Sorbitol-
MacConkey agar) were preserved for future analysis.  
For isolation of Salmonella spp., 5 gram of each sample was added to 45 ml 
Tetrathionate broth (BD Diagnostics, Sparks, MD) and then incubated at 37°C for 
24h, after which 30-40 μl of the dilution was streaked onto XLT4 agar plates (XLT4 
agar base with XLT4 supplement, BD Diagnostics, Sparks, MD). Plates were 
incubated at 37°C and examined at 24 to 48 h for presumptive Salmonella (black 
colonies). When multiple phenotypes present, at least one isolate of each phenotype 
was selected. Presumptive Salmonella colonies (at least five randomly chosen isolates 
per sample) were transferred from XLT4 plates onto Brilliant Green, and L-Agar 




incubated at 37°C for 24 h. Colonies that exhibited the Salmonella phenotype (pink 
on brilliant green) were preserved and stored at – 80°C for future analysis. 
Two Salmonella isolates per sample, when present, were classified into 
serogroups using a PCR method described by Karns et al. (2015). The method 
classifies Salmonella enterica subsp. enterica into serogroup B, C1, C2, C and E, 
which accounts for the majority of the isolates associated with human foodborne 
outbreaks. DNA was extracted using InstaGene Matrix (Bio-Rad Laboratories, 
Hercules, CA) following the manufacturer’s directions and extracted DNA samples 
were stored at -20°C. Not all serotypes fall within the 5 serogroups identified by this 
PCR analysis and isolates that were not classified into one of the 5 groups were 
categorized as Group Unknown (U). Serogroup K comprising Cerro, a serotype that is 
commonly isolated from northeastern U.S. dairy farms, is not detected by this method 
and thus was categorized as Group U. One Salmonella isolate per serogoup was 
selected for each farm, and sent to the National Veterinary Services Laboratories 
(U.S. Department of Agriculture, Animal and Plant Health Inspection Service, Ames, 
IA) for serotype classification. 
 
3.2.3 Antimicrobial susceptibility testing 
Selected Salmonella and E. coli isolates were replicated on Mueller Hinton 
agar supplemented with NARMS breakpoint concentrations of ampicillin (32 μg/ml), 
cefoxitin (32 μg/ml), chloramphenicol (32 μg/ml), cefotaxime (E. coli only) (4 




ciprofloxacin (4 μg/ml for E. coli and 1 μg/ml for Salmonella), incubated 18 h at 
37°C, and scored for growth. An isolate representing each unique resistance pattern 
per sample was then further assayed for susceptibility to a panel of 14 antibiotics on 
NARMS GN Panel via the Sensititre automated antimicrobial susceptibility system 
(Trek Diagnostic Systems, Westlake, OH). The breakpoint values used for each 
antibiotic on NARMS Panel are listed in Table 1. Results were interpreted according 
to Clinical and Laboratory Standards Institute (CLSI) standards where available. In 
the absence of a CLSI value, minimum inhibitory concentrations (MICs) were 
interpreted using the breakpoints as described by the NARMS (FDA, 2012). Isolates 
were classified as being resistant or susceptible to each agent; those few isolates with 
intermediate susceptibility were categorized as being susceptible. Enterococcus 
faecalis ATCC 29212, Pseudomonas aeruginosa ATCC 27853, and Staphylococcus 
aureus ATCC 29213 were used as quality control organisms to ensure the validity of 




Table 1. Antimicrobials used to test resistance of E. coli isolates in this study with 
broth microdilution method. Fourteen antimicrobial agents on NARMS GN Panel can 
be categorized into 9 classes according to Clinical and Laboratory Standards Institute 










Penicillins Ampicillin AMP 
≥ 32 











Ceftiofur TIO ≥ 8 
Ceftriaxone AXO 
≥ 4 
Aminoglycosides  Gentamycin GEN ≥ 16 
 Streptomycin STR ≥ 64 
Folate Pathway 
Inhibitors 





Tetracyclines  Tetracycline TET ≥ 16 
Phenicols  Chloramphenicol CHL ≥ 32 
Macrolides  Azithromycin AZI >16 
Quinolones  Ciprofloxacin CIP >4 E. coli 
≥ 1 Salmonella 




3.2.4 Analysis for blaCTX-M and blaCMY genes 
DNA was isolated from bacterial biomass using InstaGene Matrix (Bio-Rad, 
Hercules, California) following the manufacturer’s instructions. Isolates were 
analyzed for the presence of the plasmid mediated AmpC β-lactamase gene, blaCMY, 
using a PCR method developed by Zhao et al. (2003) and modified as described 
previously (Van Kessel et al., 2013; Zhao et al., 2003). The master mix consisted of 
50 pmol of each primer (cmyF and cmyR or CS5’ and CS3’), 200 μM of each 
deoxynucleoside triphosphate, 2 mM MgCl2, and 1.5 U of Ampli Taq Gold enzyme 
(Applied Biosystems, Foster City, CA). Each 25-μl reaction mixture consisted of 24 
μl of master mix and 1 μl of template DNA. The cycle included a 10-min enzyme 
activation step at 94°C and 30 cycles of 94°C for 1 min, 50°C for 90 s, and 72°C for 
90 s, followed by a 10-min final extension step at 72°C. Two strains of Salmonella 
enterica serotype Typhimurium were used as positive (CVM 1290) and negative 
(CVM 785) controls. 
The presence of the extended-spectrum β-lactamase gene, blaCTX-M, was 
determined using a multiplex PCR method developed by Woodford et al. (2005) with 
a few modifications. The master mix consisted of 50 pmol of each primer (Group 1 F, 
Group 1 R, Group 2 F, Group 2 R, Group 9 F, Group 9 R, Group 8/25 F, and Group 
8/25 R). The amplification conditions included 5-min initial enzyme activation at 
94°C and 30 cycles of 94°C for 25 s, 52°C for 40 s, and 72°C for 50 s, followed by a 
6-min elongation step at 72°C. Four in-house strains were used as positive controls: 





3.2.5 Statistical Analysis 
 A farm was considered Salmonella positive when Salmonella was isolated 
from at least one fecal composite samples from the farm. A farm was considered AR 
E. coli positive when resistant E. coli was isolated from at least one fecal composite 
samples from the farm. PROC FREQ procedure in SAS® software (version 9.4; SAS 
Institute, Cary, NC) was used for data analysis.  
 
3.3 Results 
From November, 2013 to February, 2015 a total of 444 composite manure samples 
were collected from 80 Pennsylvania dairy herds, including samples of pre-weaned 
calves from 77 farms, post-weaned calves from 75 farms, dry cows from 72 farms, 
and 219 samples of lactating  cows from 80 farms. As anticipated, E. coli was isolated 
from all the samples. At least 5 E. coli isolates (n=2370) were selected from each 
sample for antibiotic resistance prescreening and analysis. Salmonella was isolated 
from 13% (10/77) of pre-weaned calf samples, 25% (19/75) of post-weaned calf 
samples, 61% (44/72) of dry cow samples, and from 66% (145/219) lactating cow 
samples representing 64% (51/80) of the farms (Table 2). Salmonella was isolated 
from at least one sample from 64% of the farms. When present, 5 Salmonella isolates 
(n=2370) were selected from each sample for further characterization and antibiotic 




Table 2. Prevalence and serogroup distribution of Salmonella isolates from 
composite samples of pre-weaned calves, post-weaned calves, dry cows, and lactating 
cows on Pennsylvania dairy farms 
 





 % (n) 
C1 C2 E B U 
Pre-weaned calves 77 13.0 (10) 1 2 1 0 6 
Post-weaned 
calves1 
75 25.3 (19) 3 6 0 0 14 
        
Dry cows2 72 61.1 (44) 16 8 0 0 30 
Lactating cows3 80 63.8 (51) 35 13 0 1 39 
        
Total 80 63.8 (51) 25 15 1 1 40 
1 post-weaned calf samples from 2 farms had both C2 and U; samples from 1 farm 
had both C1 and C2; 
2 dry cow samples from 2 farms had both C2 and U; samples from 8 farms had both 
C1 and U; 
3 lactating cow samples from 25 farms had two or three different serogroups: 17 farms 
had serogroup C1 and U, 4 farms had serogroup C2 and U, 1 farm had serogroup C2 
and B, and 2 farms had all of the three most common serogroups, C1, C2, and U. 
 
When isolates were classified into serogroups, serogroup C1 was detected 
from 25 (31%) farms, serogroup C2 from 25 (19%) farms (Table 2). Isolated from 40 
farms could not be classified and were therefore grouped into serogroup U. Serogroup 
U was predominant in samples from both young and adult animal groups, seroroup 
C1 was more prevalent in adult cow samples, while seroroup C2 was more prevalent 
in calf samples. Serogroup B and E were each isolated from a single farm. When 
isolates representing each unique serogroup from each farm were analyzed, the 




classified from serogroup C1 were Montevideo, 14 (93.3%) of the 15 isolates in 
seroroup C2 were Kentucky, and 39 (97.5%) of the 40 isolates in seroroup U were 
Cerro (Table 3). One of each following serotypes were observed: Newport (serogroup 
C2), Rough (serogroup U), Muenster (serogroup E) and Paratyphi_B_var._L-tartrate+ 
(serogroup B). Our results concurred with the previous studies, indicating the 
temporal stability of Salmonella serotype distribution in this study region (Van Kessel 
et al., 2013, 2007). 
Table 3. Salmonella serogoup-prevalence in composite manure samples from 
Pennsylvania dairy farms, representative isolates and their serotypes, and percentage 
of serotypes within their corresponding serogroups 
 
Due to financial restraints, a prescreening for resistance was conducted for all 
isolates. At least five E. coli isolates (n=2370) and five Salmonella isolates (n=1095) 
from each sample, when present, were screened for antimicrobial resistance via 





% farms  
(n=80) 
Serotype 
Percent of serotype 
within the serogroup 
(No. of isolates) 
C1 25 31.3 Montevideo 100% (25) 




E 1 1.3 Muenster 100% (1) 
B 1 1.3 Paratyphi_B_var._L-
tartrate+ 
100% (1) 







reduced susceptibility to ampicillin and tetracycline, and the rest were inclusively 
susceptible to cefoxitin, chloramphenicol, streptomycin, kanamycin, and 
ciprofloxacin (data not shown). Based on the pre-screening results, resistant E. coli 
isolates were observed in manure composite samples from pre-weaned calves on 88% 
of farms, post-weaned calves on 81% of farms, dry cows on 46% of farms, and 
lactating cows on 64% of farms. Among the 8 antimicrobials, commensal E. coli were 
mostly frequently resistant to tetracycline, streptomycin, ampicillin, and kanamycin 
and the prevalence of resistant isolates from calves (detected in samples from 84%, 
68%, 62%, and 61% of the farms, respectively) were higher than those from adult 
cows (51%, 30%, 15%, and 7% of farms, respectively).  
Previous work with E. coli isolated from dairy animals indicated that isolates 
identified as pan-susceptible via the pre-screening method were also pan-susceptible 
when tested for resistance to the NARMS GN Panel for antimicrobial resistance via 
broth microdilution method (data not shown). In the present study, 30 pan-susceptible 
isolates based on the replica plating (presreening) results were randomly selected, and 
then confirmed pan-susceptible on the NARMS GN Panel. 
Based on the pre-screening results, 376 E. coli isolates were selected to 
represent unique resistance profiles from each sample, and the resistant phenotypes 
were further characterized for MICs by the broth microdilution test. E. coli isolates 
that exhibited resistance to at least one antimicrobial on the NARMS GN Panel 
(n=285) were identified in 42.34% (188/444) of samples from 97.5% (78/80) of 




resistant in pre-screening were pan-susceptible, indicating that the replica plating 
yielded an appreciable number of false positive results, and therefore was a relatively 
conservative method for selecting resistant bacteria isolates. 
Among the E. coli isolates showing resistance to at least one antibiotic, 93.3% 
were resistant to tetracycline, and the other common resistances were to sulfisoxazole 
(56.1%), streptomycin (53.0%) and ampicillin (41.8%). E. coli was rarely resistant to 
ciprofloxacin (1.4%), azithromycin (1.8%), nalidixic acid (4.2%), or gentamycin 
(5.3%) (Figure 1) (Table 4). Even though resistance was infrequent to some of the 
antimicrobials, at least one E. coli isolate was identified as resistant to each of the 
antibiotics on the panel. Prevalence of resistance to individual antibiotic differed 
among the four animal groups and the highest level of resistance was observed in E. 
coli isolated from pre-weaned calf samples (Figure 1). On more than 30% of the 
farms, pre-weaned calf E. coli isolates were detected resistant to each of the following 
agents: amoxicillin-clavulanic acid (Augmentin), ampicillin, cefoxitin, ceftiofur, 
ceftriaxone, streptomycin, sulfisoxazole, and tetracycline. The prevalence of resistant 
E. coli from the adult animal groups was much lower than in the calf samples, and no 
isolates were identified with resistance to azithromycin, ciprofloxacin, gentamycin, or 
















Figure 1. Resistant to individual antimicrobial agents among selected Escherichia coli isolates from four animal groups in 





Table 4. Prevalence of antimicrobial-resistant E. coli isolates (n=285) from manure 
samples of pre-weaned calves, post-weaned calves, dry cows, and lactating cows 
Antimicrobial 
Agents 










AUG 40.3 (31) 14.7 (11) 0.0 (0) 5.0 (4) 
AMP 57.1 (44) 33.3 (25) 1.4 (1) 12.5 (10) 
AZI 2.6 (2) 1.3 (1) 0.0 (0) 0.0 (0) 
FOX 37.7 (29) 13.3 (10) 0.0 (0) 5.0 (4) 
TIO 31.2 (24) 12.0 (9) 0.0 (0) 5.0 (4) 
AXO 36.4 (28) 13.3 (10) 0.0 (0) 6.3 (5) 
CHL 29.9 (23) 18.7 (14) 1.4 (1) 1.3 (1) 
CIP 1.3 (1) 1.3 (1) 0.0 (0) 0.0 (0) 
GEN 13.0 (10) 5.3 (4) 0.0 (0) 0.0 (0) 
NAL 7.8 (6) 4.0 (3) 0.0 (0) 0.0 (0) 
STR 70.1 (54) 38.7 (29) 6.9 (5) 21.3 (17) 
FIS 67.5 (52) 44.0 (33) 11.1 (8) 22.5 (18) 
TET 81.8 (63) 69.3 (52) 26.4 (19) 40.0 (32) 






Figure 2. Resistance to each number of antibiotic classes among selected (n=285) E. 
coli tested for antimicrobial susceptibility using broth microdilution method on 
NARMS GN Panel. E. coli isolates were from manure samples of pre-weaned calves, 
post-weaned calves, dry cows, and lactating cows in 80 Pennsylvania dairy farms. 
 
Among the isolates that were characterized as resistant to at least one 
antibiotic, the most common resistance patterns were TET only (68 isolates from 
56.3% of farms), STR-FIS-TET (36 isolates from 33.8% of farms), FIS-TET (20 
isolates from 22.5% of farms), CHL-STR-FIS-TET (14 isolates from 16.5% of farms) 
and AMP-TET (14 isolates from 17.5% of farms) (Table 5). The most common 
pattern of resistance to extended-spectrum beta-lactams was AUG-AMP-FOX-TIO-




TABLE 5.  Resistance patterns among 285 E. coli isolates tested for antimicrobial 
susceptibility using broth microdilution method on NARMS GN Panel 
   
The 14 antibiotics on the NARMS GN Panel were grouped into 9 classes: 
penicillins, penicillins and β-lactamase inhibitors, cephems, aminoglycosides, folate 











1 TET 68 23.9 45 56.3 
2 STR-FIS-TET 36 12.6 27 33.8 
3 FIS-TET 20 7.0 18 22.5 
4 CHL- STR-FIS-TET 14 4.9 13 16.3 
5 AMP-TET 14 4.9 14 17.5 
6 STR-TET 12 4.2 10 12.5 
7 AUG-AMP-FOX-TIO-AXO- STR-FIS-TET 9 3.2 8 10.0 
8 AUG-AMP-FOX-TIO-AXO-CHL- STR-FIS-TET 7 2.5 6 7.5 
9 AMP-FIS-TET 6 2.1 6 7.5 
11 AUG-AMP-FOX-TIO-AXO 6 2.1 4 5.0 




6 2.1 4 5.0 
14 AMP-STR-TET 4 1.4 4 5.0 
15 AMP- STR-FIS-TET 4 1.4 4 5.0 
16 AUG-AMP-FOX-AXO- STR-FIS-TET 4 1.4 4 5.0 




4 1.4 3 3.8 
19 AMP-STR-FIS-TET-SXT 3 1.1 1 1.3 




resistance (MDR), here defined as resistance to three or more classes of antimicrobial 
agents, was observed in isolates from 70% of farms in pre-weaned calf samples, 39% 
of farms in post-weaned calf samples, 6% of farms in dry cow samples, and 20% of 
farms in lactating cow samples (Figure 3) (Table 6). Resistance to up to 8 antibiotic 
classes was observed in E. coli isolates from pre-weaned and post-weaned calves. The 
highest observed resistance in adult animals was to 5 drug classes which was 

































Figure 3. Cumulative prevalence of multiple-classes of drug resistance E. coli for 






Table 6. Cumulative prevalence of multiple-classes of drug resistance E. coli for pre-
weaned calves, post-weaned calves, dry cows and lactating cows 
Classes of 
Antibiotics 











8 2.6 (2) 2.7 (2) 0.0 (0) 0.0 (0) 6.3 (5) 
≥ 7 5.2 (4) 2.7 (2) 0.0 (0) 0.0 (0) 8.8 (7) 
≥ 6 20.8 (16) 6.7 (5) 0.0 (0) 0.0 (0) 25.0 (20) 
≥ 5 39.0 (30) 13.3 (10) 1.4 (1) 1.3 (1) 46.3 (37) 
≥ 4 57.1 (44) 24.0 (18) 1.4 (1) 3.8 (3) 62.5 (50) 
≥ 3  70.1 (54) 38.7 (29) 5.6 (4) 20.0 (16) 82.5 (66) 
≥ 2 76.6 (59) 56.0 (42) 11.1 (8) 31.3 (25) 92.5 (74) 
≥ 1 84.4 (65) 70.7 (53) 27.8 (20) 43.8 (35) 97.5 (78) 
 
The AmpC phenotype was identified in E. coli isolates from 28 pre-weaned 
calf samples, 10 post-weaned calf samples, and 4 lactating cow samples from 40% 
(32/80) of farms, while this phenotype was never identified in dry cow isolates (Table 
7). Based on the PCR results, blaCMY-2 genes were detected in AmpC phenotype E. 
coli isolates from 37 samples on 35% (28/80) of farms. The prevalence of blaCMY-2 -
carrying E. coli in pre-weaned calf, post-weaned calf, and lactating cow samples was 
31%, 13%, and 4%, respectively (Table 8). On one (1% 1/80) farm, blaCMY-2 was 
found in E. coli isolates from pre-weaned calves, post-weaned calves, lactating cows, 
but not dry cows. The blaCMY-2 genes were detected in both pre-weaned calf and post-
weaned calf samples from 7 (9%) farms. In addition, E. coli encoding the blaCTX-M 
gene were isolated from 4 samples in 4 (5%) different farms, one from pre-weaned 
calf, one from post-weaned calf, one from lactating cow, and another from an 




Table 7. Prevalence of MDR AmpC phenotype E. coli and blaCMY-2 gene-carrying E. 
























animals (No. of 
farms) based 
on PCR 
Pre-weaned calves 28 - 24 31.2 - 
Post-weaned calves 10 8 10 13.3 7 
Dry cows 0 0 0 0.0 0 
Lactating cows 4 3 3 4.2 2 
Total  32 (42 
samples) 




Table 8. Prevalence of E. coli containing blaCMY-2 and blaCTX-M in pre-weaned calves, 
post-weaned calves, dry cows and lactating cows 
 blaCMY-2  blaCTX-M 
 

















Pre-weaned calves 24 31.2 -  1 1.3 - 
Post-weaned calves 10 13.3 7  1 1.3 0 
Dry cows 0 0.0 0  0 0.0 0 
Lactating cows 3 4.2 2  1 1.4 0 
Total 28 
(37 samples) 








Figure 4. PCR assay for genes encoding acquired cephalosporins-resistant genes in 
AmpC-/ESBL- phenotype E. coli isolated from Pennsylvania dairy herds. 
 
3.4 Discussion 
The use of antimicrobial drugs in agriculture is believed to contribute to the 
emergence of antimicrobial resistance, but which role in the selection for resistant 
bacteria has not been completely described (USDA, 2014). In the present study, a 
cross-sectional survey of dairy farms was conducted in Pennsylvania to determine the 
prevalence and profile of antibiotic resistant bacteria on dairy farms. Within-farm 
comparisons were made of prevalence among pre-weaned calves, post-weaned 
calves, dry cows and lactating cows.  
Salmonella is one of the leading foodborne pathogens in the U.S. and 
emergence of antibiotic resistant Salmonella in human infections is particularly 
serious due to increased morbidity and mortality (Varma et al., 2005). Dairy cows are 




severe illness in calves and cows, resulting in loss of productivity and impairment on 
animal health. In addition, subclinical shedding of Salmonella is commonly observed 
in dairy cows and may be quite extensive (Van Kessel et al., 2012; Van Kessel et al., 
2007). Even though the asymptomatic persistence of salmonellosis may not affect 
herd health and production, it presents a significant food safety and public health 
issue. Human are at risk of salmonellosis when consuming raw milk or unpasteurized 
dairy products. In United Sates, 60% of the states permit sales of raw milk in some 
form according to 2011 Raw Milk Survey (National Association of State Departments 
of Agriculture, 2011). Also, cull dairy cows contribute significantly to the ground 
beef supply in the U.S, and can cause human salmonellosis when ground beef is 
improperly prepared (Troutt, 2001). Thus, it is importance to control asymptomatic 
shedding of Salmonella on dairy farms.  
Consecutive cross-sectional studies by the National Animal Health 
Monitoring System (NAHMS) coordinated by USDA have shown an increase in 
Salmonella prevalence on U.S. dairy operations from 21% in 1996 to 40% in 2007 
(APHIS, 2009). In another cross-sectional survey in 2002, Salmonella was detected in 
56% of 16 farms from 4 states (Callaway et al., 2005). In the present study, the 
prevalence was observed to be 64% at the premise level which is higher than the 
results of previous surveys. Results from each of these studies were based on one-
time sampling and may cause underestimation of the prevalence, because Salmonella 
shedding can be intermitant: on one Pennsylvania dairy farm, the shedding prevalence 
ranged from 8 to 97% in a 6-year time frame (Van Kessel et al., 2012). Factors 




management etc. (Habing et al., 2012; Wells et al., 2001). Despite the influencing 
factors, an increasing trend of Salmonella prevalence is clear for the past two 
decades. In addition, it was observed that Salmonella prevalence is lower in pre-
weaned calf and post-weaned calf samples compared with adult dairy cattle samples, 
which concurred with other studies (Berge et al., 2006). 
Antimicrobial susceptibility testing results suggest low levels of resistance in 
Salmonella spp. derived from healthy calves and cows. This result is not surprising 
given the serotype distribution data: Cerro, Montevideo and Kentucky made up the 
majority Salmonella population in the region of the current study, and resistance has 
been historically uncommon among these serotypes (APHIS, 2009; Blau et al., 2005; 
Wells et al., 2001). Serotype distribution results in the present study concurred with 
previous studies, indicating the temporal stability of Salmonella serotype distribution 
in this study region (Van Kessel et al., 2013, 2007). Cummings et al. (2013) observed 
Salmonella Cerro from clinical samples were frequently pan-susceptible. Isolates 
form cattle that have subclinical infections are more likely to be pan-susceptible than 
isolates from dairy cattle with salmonellosis (Wells 2001; Ray 2007). In a study 
examining clinical Salmonella in Northeastern U.S. from 2004 to 2011, 56% of 
isolates were resistant to at least one antimicrobial on NARMS GN Panel, with 
extended-spectrum cephalosporins resistance being the most common resistance 
phenotype (Cummings, 2013). In this study, none of the tested isolates were found to 
be resistant to any quinolones or cephalosporins, classes of antibiotics that are of 
critical importance to human medicine. Van Kessel et al. (2013) examined 




milk filters in the NAHMS 2002 and 2007 surveys, and found serotypes Newport, 
Dublin, and Typhimurium were commonly multi-drug resistant. The single S. 
Newport isolated from one of the farms in the present study was pan-susceptible, 
despite the fact that MDR S. Newport is frequently detected in bovine isolates.  
Use of antibiotics in dairy cattle are highly regulated in the U.S., although 
extra-label use of some drugs is permitted under certain circumstances (APHIS, 
2008). Sawant et al. (2005) conducted a survey of antibiotic usage on dairy herds in 
Pennsylvania. Comprehensive records from 33 farms indicated that antibiotic usage 
was greatest for calves with enteritis (36%) followed by pneumonia in calves (23%) 
and foot rot in cattle (16%). Antibiotics including beta-lactams, spectinomycin, 
florfenicol, and tetracyclines were used on these farms for both therapeutic and 
prophylactic purposes. On 70% of the farms, calves were fed medicated milk 
replacers containing oxytetracycline and neomycin and in 18% of the herds, ceftiofur 
was used in an extra-label manner to treat mastitis in lactating cattle. Beta-lactam 
antibiotics were used mostly for dry cow therapy, for clinical mastitis and sometimes 
pneumonia and metritis. The results of the study by Sawant et al. (2005) suggest that 
the use of antibiotics at sub-therapeutic levels in dairy cattle could pose selective 
pressure and result in selection of resistant strains.  
Recent studies have shown that commensal bacteria, including generic E. coli, 
serve as good indicators of antimicrobial resistance and reveal the resistance genes 
that may emerge in pathogens. In the present study, even though resistance of E. coli 




was resistant to each of the 14 antibiotics on the NARMS GN Panel. Overall, E. coli 
were most commonly resistant to tetracycline, streptomycin, trimethoprim-
sulfamethoxazole and ampicillin. High prevalence of E. coli resistant to tetracycline 
and streptomycin could be the result of feeding pre-weaned calves with antibiotic-
supplemented milk replacer. Use of neomycin could cross-select other 
aminoglycosides such as streptomycin due to the similarities of their resistance 
mechanisms (Lin, 2015). Resistance to ciprofloxacin and azithromycin were the 
lowest among all antimicrobials tested on NARMS GN Panel, which correlates with 
absence of macrolides and quinolones usage on the farms. Resistance to sulfisoxazole 
was prevalent even though usage of folate-pathway antibiotics was not reported in 
Sawant et al.’s survey. One explanation is the co-selection of sulfisoxazole genes by 
the presence of other antibiotics or chemicals.  
Prevalence of E. coli resistant to each antibiotic was always highest in pre-
weaned calf samples, followed by post-weaned calf, and was relatively low in 
lactating cows and dry cows. The prevalence of multi-drug resistant E. coli was also 
the highest compared with the other animal groups. Among E. coli resistant to at least 
one antibiotic on the NARMS GN Panel, isolates from pre-weaned calf samples were 
most commonly resistant to 4 of 9 classes of antibiotics, whereas isolates from other 
animal groups were more likely to exhibit resistance to just 1 of 9 classes of 
antibiotic. These results point to a potential selective pressure in calf gastrointestinal 
environment. Enteritis and septicemia are important clinical problems in calves and 
not generally adult cattle (Cummings et al., 2014), thus calves are frequently exposed 




given antibiotic-supplemented milk replacer as a preventative measure. According to 
the 2007 NAHMS Dairy study, 50% U.S. dairy operations used medicated milk 
replacer for claves (APHIS, 2008). Pneumonia in pre-weaned and weaned calves also 
requires antibiotic treatment (APHIS, 2008). The presence and spread of multi-drug 
resistant E. coli isolated from healthy calves is worthy of further consideration. 
Increased number of multidrug-resistant E. coli could serve as a reservoir for genes 
that encode antimicrobial resistance and facilitate the exchange of antimicrobial 
genetic determinants with other species in the environment. 
Another factor allowing the amplification of bacteria that may have 
antimicrobial resistance mechanisms that result in a high fitness cost could be the lack 
of a developed microbiota in young calves, as observed in metagenomics studies 
(Oikonomou et al., 2013). Previous study has associated increased levels of MDR 
with calves of 2 to 4 wk of age (Berge et al., 2006). Hoyle et al. (2004) observed that 
calves were rapidly colonized by ampicillin resistant E. coli, with peak prevalence in 
the 4 month-old calf group. Consistent decline of ampicillin resistant E. coli to low 
levels with increasing age of the calves was observed (p<0.001).  
Cephalosporins belong to β-lactam antibiotic family which is an important 
class of antibiotics in human medicine (WHO, 2014). Ceftriaxone, one of the third-
generation cephalosporins, is used for treatment of severe salmonellosis in children 
(Rabsch et al., 2001). In the present study, high prevalence of resistance to 
cephalosporins was observed in E. coli, especially in young animals. In the U.S., 




initially allowed to treat bovine respiratory disease and subsequently approved for 
other species, such as swine, sheep and poultry (Bradford et al., 1999). Many isolates 
resistant to ceftiofur also exhibit decreased susceptibility to cephamycins and 
extended-spectrum cephalosporins, therefore the use of ceftiofur in food animals has 
come under increasing scrutiny as a selective factor responsible for the emergence 
and dissemination of ceftriaxone-resistant enteric pathogens such as Salmonella 
(Zhao et al., 2003). Ceftiofur treatment in calves was observed to be associated with 
reduced susceptibility to ceftriaxone (Pereira, 2014). However, a causal relationship 
between ceftiofur use and occurrence or dissemination of cephalosporin-resistant 
bacteria has not been established (Daniels et al., 2009; Singer et al., 2008). 
Quinolones, including ciprofloxacin, is another class of antibiotic of critical 
importance in human medicine. Enrofloxacin is the only quinolone drug approved for 
use in food producing animals: in 2008 enrofloxacin was approved for use in 
nonlactating cows less than 20 months of age for the treatment of bovine respiratory 
disease. Because all quinolones have a common mechanisms of resistance, resistance 
to one quinolone will usually result in resistance to all other quinolones and selection 
pressure from enrofloxacin treatment could result in the selection of resistance to 
ciprofoxacin (Hopkins et al., 2005). However, it appears that in the present study the 
resistance to quinolones was low in dairy related E. coli. 
In bovine E. coli isolates, resistance to third-generation cephalosporins is 
mainly conferred by the plasmid-encoded AmpC-like CMY β-lactamases and by the 
plasmid-encoded CTX-M β-lactamases. The blaCMY-2 gene is responsible for 




β-lactamases are not inhibited by clavulanic acid. The AmpC-like resistance 
phenotype E. coli isolates were also mostly resistant to tetracycline, sulfisoxazole, 
and trimethoprim-sulfamethoxazole, and also commonly resistant to chloramphenicol 
and streptomycin. These links of resistance suggest that there is a possible co-
selection of resistance genes against commonly used antibiotics and extended-
spectrum β-lactamase producing genes. Zhao et al. (2001) have shown the presence 
of CMY gene in E. coli and Salmonella from food animals and ground meat and the 
blaCMY-2 gene was transferable from Salmonella to recipient E. coli through 
conjugation.  
The prevalence of blaCTX-M type E.coli was lower than the prevalence of 
blaCMY type E. coli. Enterobacteriaceae-associated blaCTX-M genes have become 
globally widespread within the past 30 years. Since they were first detected in the late 
1980s in Europe, various alleles of blaCTX-M have become the predominant genes 
encoding ESBL phenotype isolated from human clinical isolates of E. coli and 
Klebsiella spp. in many parts of the world. In 2007, 48% of extended-spectrum 
cephalosporin-resistant E. coli from a clinical laboratory in Philadelphia, 
Pennsylvania were CTX-M type (McGettigan et al. 2009). CTX-M-type E. coli has 
been identified in livestock samples in different regions of the world, but the first 
isolation in the U.S. was by Wittum et al. (2010) from both sick and healthy dairy 
cattle in Ohio. Three clonal strains were isolated from fecal samples that carried two 
distinguishable plasmids encoding blaCTX-M-1 and blaCTX-M-79. One of the samples was 
from a calf that had recently received ceftiofur treatment. Based on a non-selective 




coli of 4.4% and an overall prevalence of blaCMY-positive E. coli of 32.1% in 
Washington State dairy farms. Our results also further demonstrated high prevalence 
blaCMY-2
+ E. coli in pre-weaned calves across all animal groups, which was also 
observed in the Washington State survey. 
In spite of the co-existence of Salmonella and multi-resistant enteric E. coli, 
Salmonella remained pan-susceptible. Especially in young animal groups, the 
prevalence of multidrug resistant E. coli was as high as 70% and 39% for pre-weaned 
calves and post-weaned calves, respectively, and the prevalence of Salmonella was 
13% and 25%, respectively. It was observed that Salmonella strains did not exhibit 
any similar resistance patterns with the E. coli strains present on the same farms. 
Resistance genes weren’t readily transmitted despite E. coli’s perception as a 
supposed resistance gene pool. Further genetic characterization is needed to 
understand this phenomenon.  
3.5 Conclusions 
Salmonella was isolated from 64% dairy farms and Salmonella was more 
frequently detected from cows than from calves. The majority Salmonella isolates 
belong to serogroup C1, C2, U. Serogroup C1 were mostly S. Montevideo, C2 S. 
Kentucky, and U S. Cerro. Salmonella spp. isolates were mostly pan-susceptible. E. 
coli isolates were commonly resistant to tetracycline, sulfonamides, aminoglycosides 
and β-lactams. E. coli isolated from calves were more resistant than isolates from 
cows. E. coli resistant to up to 12 antibiotics (9 classes) on NARMS GN Panel was 




4 different farms (5%). The blaCMY gene was found in 35% of the farms surveyed. 
The results of this study indicate that resistant E. coli are more prevalent in calves 
than in adult cows within the same herd. Higher prevalence of resistant E. coli in 
calves may be due to the selective pressures associated with higher exposure to 
antimicrobials. The presence of MDR E. coli on dairy farms poses potential risks to 





Chapter 4: Pulsed-field Gel Electrophoresis Characterization of 
AmpC-/ESBL-type E. coli from Dairy Herds 
4.1 Further characterization of ESBLs/AmpC-type E. coli 
Antibiotic susceptibility test is useful to identify resistant and multidrug-
resistant microorganisms. Resistance phenotype is especially helpful to speculate the 
resistance mechanisms of interest, including extended-spectrum β-lactamases 
(ESBLs) and AmpC β-lactamases.  
ESBLs are typically inhibitor-susceptible β-lactamases that hydrolyze 
penicillins, cephalosporins, and aztreonam, and also are usually multi-drug resistant 
(Thomson, 2010). ESBLs are encoded by mobile genes and therefore ESBL genes are 
transmissible. The most frequently encountered ESBLs belong to the CTX-M, SHV, 
and TEM families. Most ESBL detection tests are growth based, with confirmatory 
tests based on a β-lactamase inhibitor potentiating (enhancing) the activity of a 
cephalosporin or aztreonam in the presence of an ESBL (Thomson, 2010). In the 
present study, ESBLs candidates were selected based on the following criteria: 
AMP+, FOX-, TIO+, AXO+, and resistance to cefotaxime/ceftazidime are significantly 
inhibited by clavulanic acid (confirmed by NARMS ESBL Panel).  
AmpC β-lactamases preferentially hydrolyze narrow-, broad-, and expanded-
spectrum cephalosporins and cephamycins and resist inhibition by clavulanate, 
sulbactam and tazobactam (Thomson, 2010). Transmissible AmpC β-lactamases, also 
referred as plasmid-mediated AmpC β-lactamases, were originated from 




encountered plasmid-mediate β-lactamases belong to the CMY, FOX, and DHA 
families, and are typically associated with multidrug resistance. Phenotypic 
insusceptibility to cephamycin i.e. cefoxitin, will distinguish AmpC β-lactamases 
from ESBLs. Due to the fact that phenotypic tests do not differentiate between 
chromosomal and plasmid-mediated AmpC β-lactamases, plasmid-mediated AmpC 
β-lactamases are most accurately detected with the PCR test. In the present study, 
selected AmpC-type candidates exhibiting phenotype AMP+, FOX+, TIO+, and AXO+ 
were tested for the presence of blaCMY gene by PCR. 
In the study described in Chapter 3, the AmpC-type extended spectrum 
cephalosporin resistant E. coli were isolated from 32 farms. AmpC-type E. coli were 
isolated from more than one animal groups in 10 farms. blaCMY
+ E. coli were detected 
in 35% of the farms and blaCTX-M
+ E. coli on 5% of the farms. However, little is 
known about how the resistance spread – both within farms and between farms. For 
example, on a given farm, is there a specific resistant E. coli strain isolated from both 
young and adult animals? Whether an E. coli strain was obtained from different 
farms? Pulsed-field gel electrophoresis (PFGE) subtyping is one of the laboratory 
techniques used to examine the epidemiological relatedness of E. coli. 
PFGE technique is used generate DNA fingerprints of bacterial isolates. 
PFGE used molecular scissors, called restriction enzymes, to cut bacterial DNA at 
certain locations known as restriction sites. These molecular scissors are selected to 
generate a small number of DNA pieces that can be separated based on size. Firstly, 
the bacteria are loaded into an agarose suspension then the bacterial cell is opened to 




with restriction enzymes and loaded onto an agarose gel. PFGE is able to separate 
large restriction fragments because an electric field that constantly changes direction 
is applied.  
4.2 Materials and methods for PFGE 
 Seven farms having at least one young animal group and one adult animal 
group harboring AmpC/ESBL phenotype E. coli were selected in this preliminary 
study. Some of the E. coli isolates included in this study were from the random 
isolation described in Chapter 3. The other E. coli were isolated from the manure 
composite samples using MacConkey agar supplemented with breakpoint 
concentrations of cefotaxime or cefepime.  
PFGE was performed following the standardized PulseNet E. coli protocol 
(Ribot et al., 2006) with a few modifications as described previously (Van Kessel et 
al., 2012). Cultures were streaked onto tryptic soy agar supplemented with 0.6% yeast 
extract (BD, Sparks, MD) and incubated overnight at 37°C, and the biomass was used 
for agarose plug preparation. The DNA in plug slices was digested with 50 U XbaI 
for 4h at 37°C. Thiourea (50 μM) was added to both the gel, composed of 1% Seakem 
Gold agarose in 0.5 Tris-borater-EDTA buffer, and the electrophoresis running 
buffer, and the gels were run on a CHEF-DR II and CHEF-DR III system (Bio-Rad, 
Hercules, California). The gels were stained with 1 μg/ml ethidium bromide, and 
images were obtained using a ChemiDoc XRS gel documentation system (Bio-Rad, 
Hercules, California). Bands were assigned manually, and PFGE profiles were 




were derived using the individual XbaI experiments with arithmetic average cluster 
analysis.  
4.3 Preliminary results and discussion 
The Xbal enzyme PFGE restriction digest patterns of the cephalosporin-
resistant E. coli isolates showed high level of diversity (Figure 4). Indistinguishable 
strain clusters were observed on 4 farms, 144, 111, 108 and 142. Based on the 
dendrogram (Figure 4), all three isolates from pre-weaned calves, dry cows, and 
lactating cows on farm 144 were indistinguishable (≥96% similarity, cluster B1). 
Three isolates shared identical resistance phenotype profile, except isolate R#665 had 
a MIC of 16 μg/ml for FOX (cefoxitin), which was lower than the CLSI breakpoint 
concentration for FOX (32 μg/ml), and thus was considered as “intermediate”. In the 
present study, for the convenience of data analysis, “susceptible” and “intermediate” 
were categorized as “susceptible”. It is important to point out that most FOX 
“susceptible” E. coli isolates have MIC value around 4 μg/ml (data not shown), which 
is greatly lower than 16 μg/ml. Therefore, this specific isolates exhibiting 
“intermediate” resistance to FOX should be considered as AmpC-type as the other 
two isolates from the same farm.  
On farm 111, four AmpC-type isolates from pre-weaned calves and lactating 
cows were indistinguishable (≥96% similarity, cluster B2). The 7 AmpC phenotype 
E. coli isolates from farm 111 and 144 in cluster B1 and B2 shared 90% similarity, 
and none of the isolates harbored blaCMY gene when tested with PCR. It could be 
hypothesized that an unknown plasmid-mediated AmpC-like gene was acquired by 




completely dominated by one cephalosporin resistant E. coli strain. The other 
cephalosporin resistant E. coli exhibiting AmpC phenotype was isolated from post-
weaned calves, with blaCMY gene detected by PCR.  
Isolates from farm 108 can be categorized into two distinct clusters B3 and 
C2. Identical AmpC-type E. coli (100% similarity) in cluster B3 were isolated from 
post-weaned calves, dry cows, and lactating cows. All of the isolates in cluster B3 
were carrying blaCMY genes, and only resistant to β-lactam but not any other classes 
of antibiotics. Isolates in C2 were TIO+, AXO+, FOX-, clavulanic acid inhibit CTX 
and TAZ inactivation, which are characteristic for ESBL CTX-M type except being 
resistant to Augmentin. This uncommon resistance phenotype implicated the presence 
of multiple β-lactamase genes, possibly including ESBL gene. Overall, the 
dendrogram of farm 108 (Figure 4) showed clonal within-farm-spread of 
cephalosporin-resistant E. coli strains, and co-existence of two different 
cephalosporin-resistant strains on the same farm.  
Cluster C1 included two identical isolates from farm 142, one from post-
weaned calves and one from dry cows. Another isolate from pre-weaned calves on 
farm 142 exhibited ~87% similarity with the two isolates in cluster C1. The other two 
farm 142 isolates belonged to clusters A and, B, well removed from cluster C. All of 
the isolates from farm 142, as well as farm 35, 80, and 82, carried blaCMY genes. The 
heterogeneity of these E. coli isolates suggested that blaCMY genes were likely 
obtained through multiple independent acquisitions by different E. coli strains, or that 




Within-farm cephalosporin-resistant E. coli, isolated from different animal 
groups, were commonly observed to be identical strains. However, resistant E. coli 
isolates sampled from different farms were not found to be closely related. The 
highest between-farm similarity observed was between the pre-weaned calf isolates 
from farms 80 and 142, sharing 94% similarity (cluster C). In cluster A, a pre-weaned 
calf isolate from farm 142 and a lactating cow isolate from farm 35 exhibited ~92% 
similarity. The majority of E. coli strains from separate farms were distinct (<80% 
similarity). 
Even though only 7 farms were examined in this preliminary study, the clonal 
spread of ESBL-/AmpC-type E. coli was commonly observed (57%, 4 out of 7) 
among young and adult animal groups within individual farms. In general, a high 



























Figure 5. Dendrogram of Xbal pulsed-filed electrophoresis of selected cephalosporins resistant E. coli isolates from manure 
composite samples from pre-weaned calf, post-weaned calf, dry cow and lactating cow on 6 farms in Pennsylvania. Isolates were 
obtained through random isolation or direct isolation through spiral plating on MacConkey Agar supplemented with breakpoint 






Chapter 5: Suggestions for Future Research 
Antibiotics are a primary defense against many bacterial diseases in both 
human and veterinary medicine. Thus, efforts to promote the appropriate use of 
antimicrobials in both humans and animals and to enhance surveillance are essential 
for controlling multidrug resistance of bacterial pathogens. Antibiotics need to be 
used more prudently in both human and veterinary medicine in order to slow down 
resistance gene distribution and prevent the emergence of new resistance genes 
(Allen, 2014). In this study, farmers from each farm were asked to fill out a short 
survey about farm demographics and practices, including antibiotic use. Analysis of 
these survey results in the future would be helpful to evaluate the correlation of 
antibiotic use and prevalence of resistant bacteria. 
The high prevalence of blaCMY-type E. coli on dairy farms is a public health 
concern. The resistant E. coli in calves might serve as a reservoir for antimicrobial-
resistance genes on dairy operations. Additional research is needed on the 
mechanisms of how the resistant E. coli strains persist in calves. In the current study, 
the PFGE subtyping of ESBL-/AmpC-type E. coli has been successfully applied to 
identify epidemiological relatedness within a farm at a single point in time, but one 
limitation is that the level of resolution provided by PFGE allows only limited 
phylogenetic inferences. Thus, further characterization of mobile elements and 
genome sequencing of E. coli will allow a higher resolution epidemiological 
investigation into patterns of dissemination over a larger geographical area and longer 




would be useful in the future for more detailed analyses of antibiotic resistant 






Table A1. Salmonella serogroup combinations in lactating cow samples on 
Salmonella positive farms 
Serotype Combinations 
No. of farms 
Farm percentage 
(%) C1 C2 U B 
1 0 1 0 17 21.3 
0 0 1 0 16 20 
0 1 0 0 5 6.3 
1 0 0 0 5 6.3 
0 1 1 0 4 5 
1 1 1 0 2 2.5 
0 1 0 1 1 1.3 
1 1 0 0 1 1.3 
0 0 0 0 29 36.3 
 
 
Table A2. Resistance to each antibiotic tested on NARMS GN Panel among E. coli 




No. of Isolates % (n=285) 
AUG 32 74 26.0 
AMP 32 119 41.8 
AZI >16 5 1.8 
FOX 32 69 24.2 
TIO 8 61 21.4 
AXO 4 70 24.6 
CHL 32 49 17.2 
CIP >4 4 1.4 
GEN 16 15 5.3 
NAL 32 12 4.2 
STR 64 151 53.0 
FIS >256 160 56.1 
TET 16 266 93.3 






Table A3. Number of E. coli resistant to each total number of antibiotics on NARMS 
GN Panel among E. coli exhibiting resistance to at least one antibiotic on the panel 
(n=285) isolated from each type of samples 
No. of 
Antimicrobials to 



















1 73 25.6 14 27 13 7 6 6 
2 48 16.8 13 19 4 3 7 2 
3 47 16.5 15 17 3 6 2 4 
4 24 8.4 15 6 0 1 1 1 
5 25 8.8 15 8 1 1 0 0 
6 14 4.9 8 5 0 0 0 1 
7 10 3.5 6 3 0 1 0 0 
8 12 4.2 10 0 0 2 0 0 
9 14 4.9 10 4 0 0 0 0 
10 14 4.9 10 4 0 0 0 0 
11 3 1.1 2 0 0 0 0 0 
12 1 0.4 1 0 0 0 0 0 
 
 
Table A4. Number and percentage of E. coli exhibiting different levels of resistance 
on NARMS GN Panel among E. coli exhibiting resistance to at least one antibiotic on 
the panel (n=285) isolated  





Resistant to 1-3 
antibiotics 
168 59.0 168 59.0 
Resistant to 4-8 
antibiotics 
85 29.8 253 88.8 
Resistant to 9-
12 antibiotics 





Table A5. Prevalence of E. coli resistant to each total number of antibiotics on 
NARMS GN Panel among E. coli exhibiting resistance to at least one antibiotic on 
the panel (n=285) for each type of samples. Prevalence were also calculated for 
young and adult animal samples, respectively, and on farm-level 
No. of 
Antimicrobials to 


















1 16.0 32.0 38.0 17.0 21.0 33.0 59.0 
2 14.0 24.0 33.0 6.0 13.0 16.0 43.0 
3 17.0 21.0 29.0 4.0 14.0 18.0 41.0 
4 18.0 8.0 25.0 0.0 4.0 4.0 29.0 
5 18.0 9.0 22.0 1.0 1.0 3.0 24.0 
6 10.0 7.0 15.0 0.0 1.0 1.0 16.0 
7 8.0 4.0 10.0 0.0 1.0 1.0 11.0 
8 13.0 0.0 13.0 0.0 3.0 3.0 13.0 
9 12.0 5.0 15.0 0.0 0.0 0.0 15.0 
10 12.0 4.0 14.0 0.0 0.0 0.0 14.0 
11 3.0 0.0 4.0 0.0 0.0 0.0 4.0 





Figure A1. Resistance to various number of antibiotics among E. coli resistant to at 
least one antibiotic when tested for susceptibility using broth microdilution method 
on NARMS GN Panel (n=285). E. coli isolates were from manure samples of pre-
weaned calves, post-weaned calves, dry cows, and lactating cows in 80 Pennsylvania 






Figure A2. Resistance to various number of antibiotics among E. coli resistant to at 
least one antibiotic when tested for susceptibility using broth microdilution method 
on NARMS GN Panel (n=285). E. coli isolates were from manure samples of pre-
weaned calves, post-weaned calves, dry cows, and lactating cows in 80 Pennsylvania 
dairy farms. Young animal data were pooled from results of pre-weaned and post-
weaned samples, and adult animal data were pooled from results of dry cow and 








Figure A3. Trend lines showing accumulative prevalence of multiple-classes drug 
resistance E. coli for pre-weaned calves, post-weaned calves, dry cows and lactating 
cows. Results were based on broth microdilution method with NARMS GN Panel 








Figure A4. Resistance to various number of classes of antibiotics among E. coli 
resistant to at least one antibiotic when tested for susceptibility using broth 
microdilution method on NARMS GN Panel. E. coli isolates were from manure 
samples of dry cows, one lactating cow sample, and pooled results of up to three 
lactating cow samples. Graph suggesting that higher prevalence of resistance in 









Figure A5. MICs distribution for ceftiofur among E. coli resistant to at least one 
antibiotic when tested for susceptibility using broth microdilution method on 
NARMS GN Panel (n=285). Multinomial regression was generated using Excel 
(R2=0.99). Results suggesting CLSI cut-off is not suited for distinguishing wild and 
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